Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-2,900
Closed -$535K 23
2018
Q2
$535K Buy
+2,900
New +$513K 2.57% 8
2013
Q4
Sell
-500
Closed -$56K 177
2013
Q3
$56K Sell
500
-17,600
-97% -$1.91M 0.13% 177
2013
Q2
$1.79M Buy
+18,100
New +$1.88M 0.55% 26

Other funds holding AMGN

TradeLink Capital's AMGN Position: Q3 2018 in Review

TradeLink Capital sold out of Amgen (AMGN) in Q3 2018, closing a stake of 2,900 shares — an estimated $535K sold.

TradeLink Capital first reported a position in AMGN in Q2 2013 and held it in 3 quarters. The position peaked at $1.79M in Q2 2013. 1,796 funds tracked by Wall St. Rank hold AMGN as of Q3 2018.

  • TradeLink Capital reported no remaining Amgen position as of Q3 2018 after selling out during the quarter.
  • TradeLink Capital sold 2,900 Amgen shares in Q3 2018, an estimated $535K.
  • TradeLink Capital first reported a position in Amgen in Q2 2013 and held it in 3 quarters.
  • TradeLink Capital's Amgen position peaked at $1.79M in Q2 2013.
  • 1,796 funds tracked by Wall St. Rank held Amgen as of Q3 2018.

Based on TradeLink Capital's 13F filing for Q3 2018, filed 5 Nov 2018.